26 results
S-1
EX-10.11
AGIO
Agios Pharmaceuticals Inc
10 Jun 13
IPO registration
12:00am
anticipate that you will make many important contributions to our Company and strategic mission. Please acknowledge your acceptance of this offer
DEFA14A
EX-99.2
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
7:10am
are at an inflection point For more than a decade, our mission has been to create differentiated, small molecule medicines for patients. Our successes … our clinical pipeline Continue to deliver groundbreaking science with an energized focus and mission and funding to adequately support and develop
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Regulation FD Disclosure
7:04am
are at an inflection point For more than a decade, our mission has been to create differentiated, small molecule medicines for patients. Our successes … our clinical pipeline Continue to deliver groundbreaking science with an energized focus and mission and funding to adequately support and develop
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
11 Dec 13
Other Events
12:00am
. We are delighted to extend our collaboration, building upon the unique synergies and a shared mission to help cancer patients live longer and better
8-K
EX-99.1
do742bsc
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
EX-99.1
q42068vwoq qz5
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.1
8uo8d0nnletw kf4q
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
EX-99.1
pvdpl4wwg
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
DEFA14A
r61fvi6b
12 Jan 21
Additional proxy soliciting materials
5:15pm
8-K
EX-99.1
x398az mirgolv3j4t
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
EX-99.1
8br pdupkf7r3qfcn6r
16 Oct 15
Regulation FD Disclosure
12:00am
8-K
EX-99.2
aev1q1s
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am